Carlyle Mozart Coinvestment Holdings, L.P. 4

What Happened
Carlyle Mozart Coinvestment Holdings, L.P. (a 10% owner) converted Medline common units into Class A common stock on March 4 and March 5, 2026. The filing shows conversions of 8,085,116 shares on March 4 and 1,212,767 shares on March 5 (total 9,297,883 shares acquired). Related entries show derivative cancellations/dispositions recorded at $0.00 (these reflect cancellation of Class B shares or other derivative bookkeeping, not cash sales). After these exchanges, Carlyle Mozart holds 16,125,094 shares of Medline Class A common stock.

Key Details

• Transaction dates & amounts: Mar 4, 2026 — 8,085,116 shares (conversion); Mar 5, 2026 — 1,212,767 shares (conversion). Total acquired = 9,297,883 shares.
• Reported price: conversion/cancellation lines show $0.00 for the derivative/disposed items (no cash sale proceeds).
• Shares owned after transaction: 16,125,094 Class A shares by Carlyle Mozart Coinvestment Holdings, L.P. (plus substantial holdings across related Carlyle entities per footnotes).
• Notable footnotes: exchanges reflect one-for-one conversion of Medline Holdings LP Common Units to Class A shares (F1, F9); Class B shares have no economic value and are cancelled upon exchange (F7, F8); exchange rights are ongoing (F2). Complex Carlyle ownership structure and related entities are detailed in F3–F6 and further footnotes.
• Timeliness: filing dated Mar 6, 2026 for transactions on Mar 4–5 — not marked as late.
• Nature of filer: this is a 10% institutional holder conversion of units to stock, not an executive open‑market buy or sell.

Context
This was a corporate/unit exchange (conversion of Common Units to Class A shares) rather than an open‑market purchase or sale. The $0.00 lines reflect cancellation of non‑economic Class B shares/derivative items on conversion. For retail investors, note this increases the number of Class A shares held by Carlyle Mozart and related Carlyle entities but does not indicate a market trade by company insiders.